Janux Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
JANX
CUSIP
47103J105
Type
Equity
Class
COM
Num filings
210
Total reported value, excl. options
$997 M
Manager Report Date Value ($000) Shares Option Type